Tech Company Financing Transactions
LabNow Funding Round
LabNow secured a $20 million Series B investment round on 11/13/2007. Investors included Sammons Enterprises and Austin Ventures.
Transaction Overview
Company Name
Announced On
11/13/2007
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series B
Investors
Sammons Enterprises (Lead Investor) (Robert Korba)
Austin Ventures (Venu Shamapant)
Proceeds Purpose
Funds will be used to complete late-stage development and launch the company's initial products, the CD4Now� BioChip and Analyzer devices, which will be used in staging and monitoring the treatment of HIV/AIDS patients worldwide.
Company Information
Company Status
Out of Business
Industry
Medical Devices & Instruments
Mailing Address
2800 B Industrial Terrace
Austin, TX 78758
USA
Austin, TX 78758
USA
Phone
Website
Email Address
Overview
LabNow, Inc., seeks to improve global health and safety through the deployment of simple, rapid, point-of-need laboratory testing. The company, headquartered in Austin, Texas, has licensed novel, platform lab-on-a-chip sensor technology from The University of Texas at Austin (UT).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Scientific Officer
James Jacobson
President
Bryon Bhagwandin
Browse more venture capital transactions:
Prev: 11/13/2007: Akermin venture capital transaction
Next: 11/13/2007: Gydget venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs